Idursulfase-IT clinical trials

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

This programme offers continued access to a medicine called Idursulfase-IT for children with Hunter syndrome. It's for those who previously took part in specific studies and who are still benefiting from the treatment, where the good effects outweigh any potential problems.